Advanced Oncotherapy (AVO)

Sector:

Health Care

 1.93p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 25.00p
  • 52 Week Low: 1.75p
  • Currency: UK Pounds
  • Shares Issued: 542.57m
  • Volume: 0
  • Market Cap: £10.44m

Advanced Oncotherapy draws third tranche of Bracknor financing

By Digital Look

Date: Friday 26 May 2017

LONDON (ShareCast) - (ShareCast News) - Advanced Oncotherapy has drawn net proceeds of £1.235m in the third tranche of its Bracknor financing.
The company is a developer of next-generation proton therapy systems for cancer treatment.

In previous statements, Advanced Oncotherapy said proceeds from the Bracknor financing would continue to be allocated to its projects and for general working capital purposes.

At 14:18 BST, shares in Advanced Oncotherapy were down 4.49% at 21.25p each.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AVO Market Data

Currency UK Pounds
Share Price 1.93p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 25.00p
52 Week Low 1.75p
Volume 0
Shares Issued 542.57m
Market Cap £10.44m

AVO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
74.4% below the market average74.4% below the market average74.4% below the market average74.4% below the market average74.4% below the market average
40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average
Income Not Available
Growth Not Available

AVO Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

AVO Key Personnel

CEO Nicolas Serandour

Top of Page